Free Trial
NYSE:ALUR

Allurion Technologies (ALUR) Stock Price, News & Analysis

Allurion Technologies logo
$0.71
-0.02 (-2.73%)
(As of 10/31/2024 ET)

About Allurion Technologies Stock (NYSE:ALUR)

Key Stats

Today's Range
$0.70
$0.78
50-Day Range
$0.57
$0.77
52-Week Range
$0.55
$4.64
Volume
54,099 shs
Average Volume
749,591 shs
Market Capitalization
$45.88 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$2.88
Consensus Rating
Buy

Company Overview

Allurion Technologies Inc. focuses on ending obesity with a weight loss platform to treat people who are overweight. Its platform, the Allurion Program, features swallowable and procedure-less intragastric balloon for weight loss (the Allurion Balloon), as well as offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion Virtual Care Suite. Allurion Technologies Inc. is headquartered in Natick, Massachusetts.

Allurion Technologies Stock Analysis - MarketRank™

See Top Rated MarketRank™ Stocks
42nd Percentile Overall Score

ALUR MarketRank™: 

Allurion Technologies scored higher than 42% of companies evaluated by MarketBeat, and ranked 749th out of 993 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Allurion Technologies has received a consensus rating of Buy. The company's average rating score is 3.20, and is based on 4 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Allurion Technologies has only been the subject of 4 research reports in the past 90 days.

  • Read more about Allurion Technologies' stock forecast and price target.
  • Earnings Growth

    Earnings for Allurion Technologies are expected to decrease in the coming year, from ($0.40) to ($0.50) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Allurion Technologies is -0.81, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Allurion Technologies is -0.81, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Read more about Allurion Technologies' valuation and earnings.
  • Percentage of Shares Shorted

    1.37% of the float of Allurion Technologies has been sold short.
  • Short Interest Ratio / Days to Cover

    Allurion Technologies has a short interest ratio ("days to cover") of 3.7, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Allurion Technologies has recently increased by 0.58%, indicating that investor sentiment is decreasing.
  • Dividend Yield

    Allurion Technologies does not currently pay a dividend.

  • Dividend Growth

    Allurion Technologies does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    1.37% of the float of Allurion Technologies has been sold short.
  • Short Interest Ratio / Days to Cover

    Allurion Technologies has a short interest ratio ("days to cover") of 3.7, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Allurion Technologies has recently increased by 0.58%, indicating that investor sentiment is decreasing.
  • News Sentiment

    Allurion Technologies has a news sentiment score of -0.50. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.68 average news sentiment score of Medical companies.
  • Search Interest

    4 people have searched for ALUR on MarketBeat in the last 30 days. This is an increase of 300% compared to the previous 30 days.
  • MarketBeat Follows

    6 people have added Allurion Technologies to their MarketBeat watchlist in the last 30 days. This is an increase of 100% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Allurion Technologies insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    20.00% of the stock of Allurion Technologies is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    Only 21.39% of the stock of Allurion Technologies is held by institutions.

  • Read more about Allurion Technologies' insider trading history.
Receive ALUR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Allurion Technologies and its competitors with MarketBeat's FREE daily newsletter.

ALUR Stock News Headlines

Penny stocks October Fall
October's 4 Best Penny Stocks: High-Risk, High-Reward Picks (ALUR)
Penny stocks are a risky but potentially rewarding opportunity for investors willing to take on their uncertainty; these stocks may stand out from the pack.
The secret supplier behind NVIDIA, Tesla and Microsoft
The Biggest AI firms in the world...Tesla... Microsoft... NVIDIA... Are all relying on a little-known supplier, which provides a crucial building block for AI.
ALUR Allurion Technologies Inc.
See More Headlines

ALUR Stock Analysis - Frequently Asked Questions

Allurion Technologies' stock was trading at $3.74 on January 1st, 2024. Since then, ALUR shares have decreased by 80.9% and is now trading at $0.7128.
View the best growth stocks for 2024 here
.

Allurion Technologies Inc. (NYSE:ALUR) issued its quarterly earnings data on Tuesday, August, 13th. The company reported $0.01 earnings per share for the quarter. The company had revenue of $11.77 million for the quarter.

Shares of ALUR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that Allurion Technologies investors own include NVIDIA (NVDA), Meta Platforms (META), Nuvation Bio (NUVB), Taiwan Semiconductor Manufacturing (TSM), Advanced Micro Devices (AMD), Amprius Technologies (AMPX) and Applied Digital (APLD).

Company Calendar

Last Earnings
8/13/2024
Today
10/31/2024
Next Earnings (Confirmed)
11/13/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Medical Devices
Sub-Industry
Medical Equipment
Fax
N/A
Employees
501
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$2.88
High Stock Price Target
$5.00
Low Stock Price Target
$2.00
Potential Upside/Downside
+313.1%
Consensus Rating
Buy
Rating Score (0-4)
3.20
Research Coverage
5 Analysts

Profitability

Net Income
$-80,610,000.00
Pretax Margin
-77.83%

Debt

Sales & Book Value

Annual Sales
$47.59 million
Book Value
($1.48) per share

Miscellaneous

Free Float
51,479,000
Market Cap
$44.80 million
Optionable
Optionable
Beta
-0.33
13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report

This page (NYSE:ALUR) was last updated on 10/31/2024 by MarketBeat.com Staff
From Our Partners